A Phase 1 Study Of CP- 870,893 In Combination With Paclitaxel And Carboplatin In Patients With Metastatic Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Carboplatin (Primary) ; CP 870893; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 18 Nov 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 18 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.